These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15569398)

  • 1. Treatment of Raynaud's phenomenon with escitalopram.
    Buecking A; Rougemont E; Fabio Zullino D
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):307-8. PubMed ID: 15569398
    [No Abstract]   [Full Text] [Related]  

  • 2. Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
    Korkmaz S; Işik U; Korkmaz H
    Turk Psikiyatri Derg; 2011; 22(2):132-3. PubMed ID: 21780344
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine].
    De Broucker T; Lhote F
    Ann Med Interne (Paris); 2000 Sep; 151(5):424-5. PubMed ID: 11033481
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine-induced Raynaud's phenomenon.
    Rudnick A; Modai I; Zelikovski A
    Biol Psychiatry; 1997 Jun; 41(12):1218-21. PubMed ID: 9171912
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H; Li T; Li G; Luo J
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preclinical observation that escitalopram possesses a faster time to onset of efficacy than citalopram.
    Håkanson R
    Pharmacol Toxicol; 2002 Jan; 90(1):3-4. PubMed ID: 12005110
    [No Abstract]   [Full Text] [Related]  

  • 9. Facial dermatitis artefacta in a nine-year-old: fair response to escitalopram.
    Kumar S; Kumar U
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E7-10. PubMed ID: 23224493
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of escitalopram on sleep problems in depressed patients.
    Lader M; Andersen HF; Baekdal T
    Hum Psychopharmacol; 2005 Jul; 20(5):349-54. PubMed ID: 15912558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of escitalopram in psychogenic excoriation.
    Pukadan D; Antony J; Mohandas E; Cyriac M; Smith G; Elias A
    Aust N Z J Psychiatry; 2008 May; 42(5):435-6. PubMed ID: 18499934
    [No Abstract]   [Full Text] [Related]  

  • 17. Duloxetine in treating medically unexplained pain and Raynaud's phenomenon.
    Li CT; Chou YH; Su TP
    J Neuropsychiatry Clin Neurosci; 2009; 21(4):475-6. PubMed ID: 19996264
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy of lamotrigine and escitalopram may cause myoclonus.
    Rosenhagen MC; Schmidt U; Weber F; Steiger A
    J Clin Psychopharmacol; 2006 Jun; 26(3):346-7. PubMed ID: 16702909
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.
    Yu AP; Xie J; Bensimon A; Parikh K; Wu EQ; Ben-Hamadi R; Blum S; Haim Erder M
    J Med Econ; 2010; 13(4):599-609. PubMed ID: 20879834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Escitalopram: a chiral agent for treatment of depression].
    Overlack M; Davids E; Gastpar M
    Med Monatsschr Pharm; 2004 May; 27(5):148-51. PubMed ID: 15171592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.